Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BentallGreenOak (BGO) is a leading global real estate investment management advisor and a provider of real estate services, serving the interests of more than 750 institutional clients. While not a biotechnology or pharmaceutical company itself, BGO is a major player in the life sciences sector through its extensive portfolio of specialized laboratory, research, and development facilities. The firm focuses on acquiring, developing, and managing high-quality properties in key innovation clusters to provide the mission-critical infrastructure required by life science companies. BGO was formed by the 2019 merger of Bentall Kennedy and GreenOak Real Estate and operates as a part of SLC Management, the institutional alternatives asset management arm of Sun Life Financial.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BentallGreenOak.